174 related articles for article (PubMed ID: 36624289)
21. Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.
Wervers K; Vis M; Tchetveriko I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Luime JJ
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1764-1770. PubMed ID: 29609220
[TBL] [Abstract][Full Text] [Related]
22. Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies.
Schneeberger EE; Citera G; Nash P; Smolen JS; Mease PJ; Soriano ER; Helling C; Szumski AE; Mundayat R; de León DP
Semin Arthritis Rheum; 2023 Feb; 58():152134. PubMed ID: 36476498
[TBL] [Abstract][Full Text] [Related]
23. Postpartum Depression in Reproductive-Age Women With and Without Rheumatic Disease: A Population-Based Matched Cohort Study.
Shridharmurthy D; Lapane KL; Nunes AP; Baek J; Weisman MH; Kay J; Liu SH
J Rheumatol; 2023 Oct; 50(10):1287-1295. PubMed ID: 37399461
[TBL] [Abstract][Full Text] [Related]
24. Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis.
van der Heijde D; Deodhar A; Fleischmann R; Mease PJ; Rudwaleit M; Nurminen T; Davies O
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1030-1039. PubMed ID: 27696727
[TBL] [Abstract][Full Text] [Related]
25. Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries.
Mease PJ; Liu M; Rebello S; Kang H; Yi E; Park Y; Greenberg JD
Rheumatol Ther; 2019 Dec; 6(4):529-542. PubMed ID: 31529278
[TBL] [Abstract][Full Text] [Related]
26. Evaluating current definitions of low disease activity in psoriatic arthritis using ultrasound.
Bosch P; Husic R; Ficjan A; Gretler J; Lackner A; Graninger WB; Duftner C; Hermann J; Dejaco C
Rheumatology (Oxford); 2019 Dec; 58(12):2212-2220. PubMed ID: 31199483
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.
D'Angelo S; Tirri E; Giardino AM; Mattucci-Cerinic M; Dagna L; Santo L; Ciccia F; Frediani B; Govoni M; Bobbio Pallavicini F; Grembiale RD; Delle Sedie A; Mulè R; Cantatore FP; Foti R; Gremese E; Conigliaro P; Salaffi F; Viapiana O; Cauli A; Giacomelli R; Arcarese L; Guggino G; Russo R; Puenpatom A; Capocotta D; Nacci F; Anelli MG; Picerno V; Binetti C; Iannone F
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887946
[TBL] [Abstract][Full Text] [Related]
28. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
Kilic E; Kilic G; Akgul O; Ozgocmen S
Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
[TBL] [Abstract][Full Text] [Related]
29. Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis.
Kieskamp SC; Paap D; Carbo MJG; Wink F; Bos R; Bootsma H; Arends S; Spoorenberg A
Rheumatology (Oxford); 2021 Oct; 60(10):4476-4485. PubMed ID: 33492397
[TBL] [Abstract][Full Text] [Related]
30. Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohort.
Reich A; Weiß A; Lindner L; Baraliakos X; Poddubnyy D; Zinke S; Stille C; Strangfeld A; Regierer AC
Arthritis Res Ther; 2023 Aug; 25(1):136. PubMed ID: 37533077
[TBL] [Abstract][Full Text] [Related]
31. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis.
Kleinert S; Schuch F; Rapp P; Ronneberger M; Wendler J; Sternad P; Popp F; Bartz-Bazzanella P; von der Decken C; Karberg K; Gauler G; Wurth P; Späthling-Mestekemper S; Kuhn C; Englbrecht M; Vorbrüggen W; Adler G; Welcker M
Rheumatol Int; 2023 Jan; 43(1):89-97. PubMed ID: 36441274
[TBL] [Abstract][Full Text] [Related]
32. Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents.
Kerola AM; Rollefstad S; Kazemi A; Wibetoe G; Sexton J; Mars N; Kauppi M; Kvien TK; Haavardsholm EA; Semb AG
Scand J Rheumatol; 2023 Jan; 52(1):42-50. PubMed ID: 35014920
[TBL] [Abstract][Full Text] [Related]
33. Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis.
Gudmann NS; Munk HL; Christensen AF; Ejstrup L; Sørensen GL; Loft AG; Karsdal MA; Bay-Jensen AC; He Y; Siebuhr AS; Junker P
Arthritis Res Ther; 2016 Jun; 18(1):141. PubMed ID: 27306080
[TBL] [Abstract][Full Text] [Related]
34. Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study.
Michielsens CAJ; den Broeder N; Mulder MLM; van den Hoogen FHJ; Verhoef LM; den Broeder AA
Rheumatology (Oxford); 2022 May; 61(6):2307-2315. PubMed ID: 34599803
[TBL] [Abstract][Full Text] [Related]
35. Associations Between Five Important Domains of Health and the Patient Acceptable Symptom State in Rheumatoid Arthritis and Psoriatic Arthritis: A Cross-Sectional Study of 977 Patients.
Puyraimond-Zemmour D; Etcheto A; Fautrel B; Balanescu A; de Wit M; Heiberg T; Otsa K; Kvien TK; Dougados M; Gossec L
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1504-1509. PubMed ID: 27998030
[TBL] [Abstract][Full Text] [Related]
36. Depression/anxiety symptoms in axial spondyloarthritis and psoriatic arthritis patients in Serbia: a pilot study.
Milutinovic S; Veljkovic K; Zlatanovic M; Radunovic G; Damjanov N
Rheumatol Int; 2019 Sep; 39(9):1595-1605. PubMed ID: 31309294
[TBL] [Abstract][Full Text] [Related]
37. Obesity, metabolic syndrome and other comorbidities in rheumatoid arthritis and psoriatic arthritis: influence on disease activity and quality of life.
Azevedo S; Santos-Faria D; Leite Silva J; Ramos Rodrigues J; Sousa Neves J; Peixoto D; Tavares-Costa J; Alcino S; Afonso C; Teixeira F
Acta Reumatol Port; 2019; 44(4):322-324. PubMed ID: 32281967
[TBL] [Abstract][Full Text] [Related]
38. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis.
Lauper K; Courvoisier DS; Chevallier P; Finckh A; Gabay C
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1756-1763. PubMed ID: 29609199
[TBL] [Abstract][Full Text] [Related]
39. Psychometric properties of the painDETECT questionnaire in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: Rasch analysis and test-retest reliability.
Rifbjerg-Madsen S; Wæhrens EE; Danneskiold-Samsøe B; Amris K
Health Qual Life Outcomes; 2017 May; 15(1):110. PubMed ID: 28532452
[TBL] [Abstract][Full Text] [Related]
40. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
